SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: AlienTech who wrote (7652)5/3/1998 3:07:00 PM
From: 777 Captain  Read Replies (1) | Respond to of 23519
 
Mr. AT: The info you provided: what do the numbers in the bottom paragraph represent, the columns are not labelled. Thanks for the input.



To: AlienTech who wrote (7652)5/3/1998 7:11:00 PM
From: E'Lane  Read Replies (2) | Respond to of 23519
 
AT
......................................................... New Rxs.....cash...Insurance
Total Prescription Drug Market..........25,410,998...24%....76%...........
Sexual Function Disorder Market.............119,810...49%...51%..........
Viagra......................................................113,134... 51%...50%.........
Muse...........................................................4,609....26%....73%........

By NEW RX's...this means no refills are counted right? Well, of course a brand new script is gonna be higher than a product already in the system!

Did you notice the insurance & cash #'s on Muse and Viagra? Insurance companies paying for a product seems to sway some people's opinions of a drug. Example..generic drugs. Insurance companies pay more on generic so people get generic. PFE won't get squat from the generics that the insurance companies will one day be paying out for. Muse is already 73% covered (right in line with total perscriptions %)...that is a plus. There might be 51% of ED patients (cash only) on "fixed incomes" who will return to MUSE for no other reason then that.

MOSBY....My opinion should be yours!
E'Lane